Connell Consulting
Essential reading for the healthcare business
 
 
Remember me:
Skip Navigation LinksHealthInvestor article
EQT to buy BSN Medical for €1.8 billion

Private equity fund EQT VI has agreed to buy medical device manufacturer BSN Medical from Montagu Private Equity for €1.8 billion (£1.4 billion).

BSN has annual sales of €700 million and around 4,000 employees. It is a major supplier of wound care, compression therapy and orthopaedic products to hospitals and pharmacies around the world.

The company was founded in 2001 as a joint venture between Beiersdorf AG and Smith & Nephew, and was acquired by Montagu Private Equity in 2005.

“We view BSN as a highly attractive growth case with strong resilience across the business cycle,” said Marcus Brennecke, partner at EQT Partners in Germany, and investment advisor to EQT VI.

“While continuing to strengthen the position in key markets and in key product segments, there is tremendous potential in entering new geographic markets, especially in Asia and Latin America. BSN’s global foot-print and large sales force provide an excellent platform for add-on acquisitions.”

BSN’s chief executive, Claus-H Wiegel, said: “We will look forward to working with EQT to deliver the next phase of BSN’s growth story.”

The transaction is subject to regulatory clearances. Morgan Stanley and Deutsche Bank acted as financial advisors to EQT VI. Goldman Sachs and HSBC acted as financial advisors to Montagu and BSN.

Posted on: 11/06/2012

Latest news stories

28/04/2017
“We are cynical about the commitment of any political organisation to private companies that are sitting here,” said Kenneth Mackenzie managing partner at Target Advisers.
28/04/2017
Margaret McKeith, Scottish Care’s national lead – Partners For Integration, appealed to local authorities to let independent providers be “true partners” in the delivery of care in Scotland.
28/04/2017
Greater transparency is required over the way local authorities fund care in Scotland, argued Robert Kilgour, speaking at the HealthInvestor Scotland Summit in Edinburgh on 27 April.
27/04/2017
CareTech has announced that trading is in line with expectations, occupancy is level, and it has “considerable headroom” for further investments.
27/04/2017
Financially troubled care home giant Four Seasons Health Care Group has seen improved financial results in 2016.



Badby Park CEO Paul Hill tells Sarah Williams how a staff-led approach is driving the complex care provider's expansion
Read more...



Company profile: SuperCarers

SuperCarers aims to use technology to disrupt the traditional home care model. Ploy Radford talks to the firm's CEO, Adam Pike, to find out more
Read more...
HealthInvestor Events

Social care staffing' already under strain, could face further pressure after Brexit. Sarah Williams asks sector leaders about their biggest fears - and what could allay them
Read more...


Christie + Co


Veterinary

With the veterinary market rapidly consolidating across Europe, Ploy Radford investigates what vet investors considering a pan-European strategy should know
Read more...



HealthInvestor blog
The Law Commission’s final report on event fees in the retirement village market will reassure investors and drive sector growth

Click here to view the Editor's blog


Partner and head of healthcare and life sciences financial advisory at Deloitte, and rally car enthusiast
Outpatient treatment for eating disorders delivers better results and is cheaper than inpatient treatment, find Clare Connell and Hallie Heeg of Connell Consulting
Dr Matteo De Martino and Dr Leonid Shapiro of Candesic predict how IVF clinics will win clients and upsell services in the future
Siemens has its eye on the US equity markets for a listing of its healthcare division. Nick Herbert takes a look at the US’ IPO appeal
SuperCarers aims to use technology to disrupt the traditional home care model. Ploy Radford talks to the firm’s CEO, Adam Pike, to find out more

Click here to search all feature articles